Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.

SZSE:300452 Stock Report

Market Cap: CN¥2.9b

Anhui Sunhere Pharmaceutical ExcipientsLtd Future Growth

Future criteria checks 2/6

Anhui Sunhere Pharmaceutical ExcipientsLtd is forecast to grow earnings and revenue by 18.1% and 15.5% per annum respectively. EPS is expected to grow by 17.8% per annum. Return on equity is forecast to be 19.1% in 3 years.

Key information

18.1%

Earnings growth rate

17.8%

EPS growth rate

Pharmaceuticals earnings growth18.9%
Revenue growth rate15.5%
Future return on equity19.1%
Analyst coverage

Low

Last updated17 May 2024

Recent future growth updates

No updates

Recent updates

Anhui Sunhere Pharmaceutical ExcipientsLtd's (SZSE:300452) Earnings Are Weaker Than They Seem

Sep 03
Anhui Sunhere Pharmaceutical ExcipientsLtd's (SZSE:300452) Earnings Are Weaker Than They Seem

Anhui Sunhere Pharmaceutical ExcipientsLtd (SZSE:300452) Has Affirmed Its Dividend Of CN¥0.25

May 26
Anhui Sunhere Pharmaceutical ExcipientsLtd (SZSE:300452) Has Affirmed Its Dividend Of CN¥0.25

Earnings and Revenue Growth Forecasts

SZSE:300452 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,223249N/A2661
12/31/20251,080215N/A2551
12/31/2024945185N/A651
9/30/202484316082110N/A
6/30/202483616987119N/A
3/31/202482916280123N/A
12/31/202383916277132N/A
9/30/202382016037123N/A
6/30/202379715331117N/A
3/31/202376114643127N/A
1/1/202370513166133N/A
9/30/202269611191124N/A
6/30/2022671102103126N/A
3/31/20226369282106N/A
12/31/20216178972104N/A
9/30/20215999876107N/A
6/30/20215799773105N/A
3/31/20215791017495N/A
12/31/2020531946486N/A
9/30/2020514913561N/A
6/30/2020499935285N/A
3/31/2020474893077N/A
12/31/2019464842079N/A
9/30/201944682-780N/A
6/30/201943778-1977N/A
3/31/201943574-1479N/A
12/31/201842970-775N/A
9/30/2018422662077N/A
6/30/201840059N/A63N/A
3/31/201837355N/A54N/A
12/31/201733950N/A64N/A
9/30/201731147N/A38N/A
6/30/201729747N/A42N/A
3/31/201729248N/A48N/A
12/31/201628649N/A55N/A
9/30/201627449N/A53N/A
6/30/201626951N/A56N/A
3/31/201626147N/A49N/A
12/31/201525944N/A43N/A
9/30/201525443N/A43N/A
6/30/201524936N/A37N/A
3/31/201524635N/A30N/A
12/31/201423935N/A37N/A
12/31/201321335N/A26N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300452's forecast earnings growth (18.1% per year) is above the savings rate (2.8%).

Earnings vs Market: 300452's earnings (18.1% per year) are forecast to grow slower than the CN market (26.3% per year).

High Growth Earnings: 300452's earnings are forecast to grow, but not significantly.

Revenue vs Market: 300452's revenue (15.5% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 300452's revenue (15.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300452's Return on Equity is forecast to be low in 3 years time (19.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y